Journalartikel - Artikel | 2022 | Peer reviewed

The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT

Autor(en)

Wittmann, Jasmin ; Groß, Melissa ; Catani, Claudia ; Schmidt, Telja Lucia ; Neldner, Sina ; Wilker, Sarah ; May, Theodor ; Ertl, Verena ; Rosner, Rita ; Zindler, Areej ; Odenwald, Michael ; Neuner, Frank

Normierter Zeitschriftentitel

Trials

DOI

10.1186/s13063-022-06288-8

PubMed-ID

35477413

URN

urn:nbn:de:0070-pub-29628299

URL

https://pub.uni-bielefeld.de/record/2962829

Web of Science-ID

000788322200006

Weitere Details

Sprache

englisch

Darstellungsform

Text

Band

Artikelnummer

360

Ausgabe

Link zum Volltext (intern)

https://pub.uni-bielefeld.de/record/2962829

DDC

150

BACKGROUND: The trial YOURTREAT aims to compare the pragmatic, short-term psychotherapy Narrative Exposure Therapy for Children (KIDNET) with treatment as usual (TAU) for the treatment of young refugees in Germany. This update outlines changes made to the study protocol in response to the current COVID-19 pandemic with the aim of allowing the continuation of the clinical trial while ensuring the safety of the staff and the participants, maintaining methodological quality, and ensuring compliance with legal regulations.; METHODS: The major amendments to the original study protocol include (1) the possibility of using telehealth technology for the conduction of diagnostic and therapy sessions, (2) a reduction of the diagnostic set, and (3) an increased flexibility in the time frame of the study protocol.; DISCUSSION: The adaptations to the study protocol made it feasible to continue with the trial YOURTREAT during the COVID-19 pandemic. Although the diagnostic set had to be shortened, the primary outcomes and the main secondary outcomes remain unimpaired by the amendment. Therefore, we expect the trial to provide evidence regarding effective treatment options for young refugees in Germany, a population that has received little scientific attention so far and has only very limited access to mental health care in the German health care system. In light of the current pandemic, which globally increases the risk of mental problems, the situation for young refugees is likely to aggravate further. Thus, the clinical and social relevance of the present trial YOURTREAT is even more important in these particular times.; TRIAL REGISTRATION: German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS) DRKS00017222 . Registered on May 15, 2019. © 2022. The Author(s).

Zitierstile

Wittmann J, Groß M, Catani C, et al. The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. Trials. 2022;23(1): 360.

In die Zwischenablage einfügen

Wittmann, J., Groß, M., Catani, C., Schmidt, T. L., Neldner, S., Wilker, S., May, T., et al. (2022). The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. Trials, 23(1), 360. https://doi.org/10.1186/s13063-022-06288-8

In die Zwischenablage einfügen

Wittmann, Jasmin, Groß, Melissa, Catani, Claudia, Schmidt, Telja Lucia, Neldner, Sina, Wilker, Sarah, May, Theodor, et al. 2022. “The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT”. Trials 23 (1): 360.

In die Zwischenablage einfügen

Wittmann, J., Groß, M., Catani, C., Schmidt, T. L., Neldner, S., Wilker, S., May, T., Ertl, V., Rosner, R., Zindler, A., et al. (2022). The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. Trials 23:360.

In die Zwischenablage einfügen

Wittmann, J., et al., 2022. The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. Trials, 23(1): 360.

In die Zwischenablage einfügen

J. Wittmann, et al., “The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT”, Trials, vol. 23, 2022, : 360.

In die Zwischenablage einfügen

Wittmann, J., Groß, M., Catani, C., Schmidt, T.L., Neldner, S., Wilker, S., May, T., Ertl, V., Rosner, R., Zindler, A., Odenwald, M., Neuner, F.: The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. Trials. 23, : 360 (2022).

In die Zwischenablage einfügen

Wittmann, Jasmin, Groß, Melissa, Catani, Claudia, Schmidt, Telja Lucia, Neldner, Sina, Wilker, Sarah, May, Theodor, Ertl, Verena, Rosner, Rita, Zindler, Areej, Odenwald, Michael, and Neuner, Frank. “The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT”. Trials 23.1 (2022): 360.

AMA

APA (6th ed.)

Chicago

Frontiers

Harvard

IEEE

LNCS

MLA